ELIZABETH BERRY: Open Payments
NPI 1134847304 · TOWN AND COUNTRY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 141 payments from 14 companies in 2025. Trend: 2023 $2,421 · 2024 $2,660 · 2025 $3,388
Food & beverage: $3,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $628 |
| E.R. Squibb & Sons, L.L.C. | 13 | $590 |
| Teva Pharmaceuticals USA, Inc. | 11 | $345 |
| Vanda Pharmaceuticals Inc. | 19 | $300 |
| Alkermes, Inc. | 19 | $280 |
| Axsome Therapeutics, Inc. | 14 | $274 |
| Otsuka America Pharmaceutical, Inc. | 13 | $267 |
| Lundbeck LLC | 11 | $193 |
| Neurocrine BioSciences, Inc. | 3 | $163 |
| Janssen Pharmaceuticals, Inc | 3 | $137 |
Products named: VRAYLAR, COBENFY, REXULTI, FANAPT, Auvelity, UZEDY, ARISTADA, INGREZZA.
Industry payments across MO — which companies pay providers there.
